Section for Affective Disorders; Northern Stockholm Psychiatry

The Section for Affective Disorders at Norra Stockholms Psykiatri (Northern Stockholm Psychiatry) is a specialist psychiatric unit within Region Stockholm, Sweden, led by Associate Professor Johan Lundberg of Karolinska Institutet; it sponsors two active psilocybin trials — the CAPSI randomized trial investigating a single oral dose of psilocybin 25 mg for cancer-related major depressive disorder in 100 patients, and the PSIPET Phase 2b PET imaging study measuring psilocybin's effect on synaptic density as a biomarker for MDD treatment response.